Table 3.
Rate of Viral Suppression (VS) and Time to VS Among Patients Who Experienced Churn and Had Transmissible Viremia on Reenrollment Compared to Those Retained in Care, Censoring for Transfer of Care and Loss to Follow-up
| Care Pattern | Patients | VS | Time to VS, da | aHRc | (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| No. | (%) | P Valueb | Median | (IQR) | ||||
| Churn | 122 | 101 | (82.8) | <.00001 | 153.5 | (49–442) | 0.59 | (.48–.73) |
| No churn | 1013 | 972 | (96.0) | 84 | (47–156) | Ref | … | |
The no-churn group includes persons with human immunodeficiency virus (HIV) who attained VS prior to churn and never had subsequent transmissible viremia. People with HIV who had VS prior to or within 14 days of their first clinic visit are excluded.
Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval; IQR, interquartile range; VS, viral suppression.
Refers to the time from reenrollment to VS for the churn group and the time from initial enrollment to VS for the no-churn group.
Calculated using χ2 testing.
Adjusted for age, sex, race/ethnicity, insurance status, alcohol use, and drug use.